Capital International Investors’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.17B | Buy |
2,635,903
+1,986,004
| +306% | +$884M | 0.2% | 104 |
|
|
2025
Q1 | $315M | Buy |
649,899
+307,387
| +90% | +$149M | 0.06% | 191 |
|
|
2024
Q4 | $138M | Buy |
+342,512
| New | +$138M | 0.03% | 257 |
|
|
2022
Q2 | – | Sell |
-125,595
| Closed | -$32.8M | – | 460 |
|
|
2022
Q1 | $32.8M | Sell |
125,595
-1,901,637
| -94% | -$496M | 0.01% | 376 |
|
|
2021
Q4 | $445M | Sell |
2,027,232
-1,922,320
| -49% | -$422M | 0.09% | 189 |
|
|
2021
Q3 | $716M | Sell |
3,949,552
-599,451
| -13% | -$109M | 0.16% | 136 |
|
|
2021
Q2 | $917M | Sell |
4,549,003
-1,493,566
| -25% | -$301M | 0.21% | 110 |
|
|
2021
Q1 | $1.3B | Sell |
6,042,569
-642,853
| -10% | -$138M | 0.33% | 84 |
|
|
2020
Q4 | $1.58B | Buy |
6,685,422
+1,199,338
| +22% | +$283M | 0.43% | 61 |
|
|
2020
Q3 | $1.49B | Sell |
5,486,084
-261,425
| -5% | -$71.1M | 0.46% | 56 |
|
|
2020
Q2 | $1.67B | Sell |
5,747,509
-795,089
| -12% | -$231M | 0.55% | 43 |
|
|
2020
Q1 | $1.56B | Buy |
6,542,598
+277,804
| +4% | +$66.1M | 0.64% | 40 |
|
|
2019
Q4 | $1.37B | Buy |
6,264,794
+3,241,404
| +107% | +$710M | 0.47% | 58 |
|
|
2019
Q3 | $512M | Buy |
3,023,390
+123
| +0% | +$20.8K | 0.2% | 121 |
|
|
2019
Q2 | $554M | Sell |
3,023,267
-66,904
| -2% | -$12.3M | 0.22% | 110 |
|
|
2019
Q1 | $568M | Buy |
3,090,171
+392,648
| +15% | +$72.2M | 0.24% | 109 |
|
|
2018
Q4 | $447M | Sell |
2,697,523
-174,400
| -6% | -$28.9M | 0.22% | 114 |
|
|
2018
Q3 | $554M | Buy |
+2,871,923
| New | +$554M | 0.25% | 100 |
|
|
2015
Q3 | – | Sell |
-111
| Closed | -$14K | – | 271 |
|
|
2015
Q2 | $14K | Buy |
+111
| New | +$14K | ﹤0.01% | 257 |
|